Contents of this document
- Impact of higher sales¥1,016 million
- Impact of higher cost ratio¥-113 million
- Impact of changes in sales mix¥-165 million
- Impact of higher selling expenses¥-261 million
- Impact of higher personnel expenses¥-98 million
- Impact of lower advertising expenses¥57 million
- Other¥-48 million
- Increased Investment in Human Capital
- Proactive promotion of research and development activities
- Strengthening Investor Relations Activities
- Investment in new businesses through M&A
- Strengthen advertising initiatives for the bottled water business in the second half
- Year-on-year increase in group headcount38 peopleYear on year against the same period last year+38 people
- Actual ROE8.5 %
- DOE4 %
- Actual PBR1.34 Times
- Water Healthcare BusinessNet Sales12,432
- Medical-related businessNet Sales1,458
- Total water ionizer salesNet Sales5,308
- CartridgesNet Sales3,232
- PT. SUPER WAHANA TEHNO (bottled water)Net Sales3,194
- Regenerative Medicine-Related BusinessNet Sales1,446
- Electrolyzed Water Dialysis BusinessNet Sales12
- Fiscal yearFiscal year ending March 2027Net Sales¥270 100 million
- Fiscal yearFiscal year ending March 2028Net Sales¥310 100 million
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings summary |
| Fiscal Period Covered | Second quarter (interim period) of the fiscal year ending March 2027 |
| Net Sales | ¥13,891 million (YoY +12.0%) |
| Operating profit | ¥1,950 million (YoY +24.8%) |
| Ordinary income | ¥2,125 million (YoY +26.8%) |
| Net income | ¥1,291 million (interim net income attributable to owners of the parent) (YoY +16.7%) |
| Gross Profit Margin | 66.4 % |
| Operating profit margin | 14 % |
| Selling, general and administrative expenses | ¥7,270 million |
| Segment results | Segment Water Healthcare Business / Net Sales ¥12,432 million / yoy_pct ¥14.4 million, Segment Medical-related business / Net Sales ¥1,458 million / yoy_pct ¥-5.2 million, Segment Total water ionizer sales / Net Sales ¥5,308 million / yoy_pct ¥5.4 million, Segment Cartridges / Net Sales ¥3,232 million / yoy_pct ¥5.3 million, Segment PT. SUPER WAHANA TEHNO (bottled water) / Net Sales ¥3,194 million / yoy_pct ¥52.1 million, Segment Regenerative Medicine-Related Business / Net Sales ¥1,446 million / yoy_pct ¥-1.3 million, Segment Electrolyzed Water Dialysis Business / Net Sales ¥12 million / yoy_pct ¥-82.8 million |
| Breakdown of Factors Affecting the Change | Factors Impact of higher sales / Amount ¥1,016 million, Factors Impact of higher cost ratio / Amount ¥-113 million, Factors Impact of changes in sales mix / Amount ¥-165 million, Factors Impact of higher selling expenses / Amount ¥-261 million, Factors Impact of higher personnel expenses / Amount ¥-98 million, Factors Impact of lower advertising expenses / Amount ¥57 million, Factors Other / Amount ¥-48 million |
| Key KPIs | Indicator name Year-on-year increase in group headcount / Value 38 people / Year on year against the same period last year +38 people, Indicator name Actual ROE / Value 8.5 % / Year on year against the same period last year Not disclosed, Indicator name DOE / Value 4 % / Year on year against the same period last year Not disclosed, Indicator name Actual PBR / Value 1.34 Times / Year on year against the same period last year Not disclosed |
| Number of employees | Number of Employees Year-on-year: +38 people / Change during the period Year-on-year: +38 people / Hiring plan Not disclosed |
| Medium-term management plan targets | Fiscal year Fiscal year ending March 2027 / Net Sales ¥270 100 million, Fiscal year Fiscal year ending March 2028 / Net Sales ¥310 100 million |
| Financial targets | ROE target At least 10% / Actual ROE 8.5% (end of March 2026) / DOE basis 4% / Actual PBR 1.34x (end of March 2026) |
| Acquisition of treasury shares | Number of shares to be acquired 25 10,000 shares / Acquisition period Fiscal year ended March 2026 |
| New initiatives | Increased Investment in Human Capital, Proactive promotion of research and development activities, Strengthening Investor Relations Activities, Investment in new businesses through M&A, Strengthen advertising initiatives for the bottled water business in the second half |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The expansion of the bottled water business and steady sales of water ionizers and cartridges drove revenue growth. While the increase in revenue contributed to operating profit, higher raw material and component prices, changes in the sales mix, and higher personnel expenses weighed on profit, while lower advertising expenses provided support.